Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
Chagas cardiomyopathy (CC), caused by the protozoan <i>Trypanosoma cruzi</i>, is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 20...
Main Authors: | Isis G. Montalvo-Ocotoxtle, Gustavo Rojas-Velasco, Olivia Rodríguez-Morales, Minerva Arce-Fonseca, Luis A. Baeza-Herrera, Arturo Arzate-Ramírez, Gabriela Meléndez-Ramírez, Daniel Manzur-Sandoval, Mayra L. Lara-Romero, Antonio Reyes-Ortega, Patricia Espinosa-González, Erika Palacios-Rosas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/24/7262 |
Similar Items
-
Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al. -
Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al. -
Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2023-12-01) -
The Burden of Chagas Disease in the Contemporary World: The RAISE Study
by: Antonio Luiz Pinho Ribeiro, et al.
Published: (2024-01-01) -
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
by: J Antonio Marin-Neto, et al.
Published: (2009-07-01)